Search

Genmab A-S

Cerrado

2,628 1

Resumen

Variación precio

24h

Actual

Mínimo

2540

Máximo

2602

Métricas clave

By Trading Economics

Ingresos

243M

295M

Ventas

259M

1.2B

P/B

Media del Sector

31.352

49.241

BPA

34.85

Margen de beneficios

25.541

Empleados

3,119

EBITDA

216M

431M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

-1.49% downside

Dividendos

By Acuity

Próximas Ganancias

5 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

43B

156B

Apertura anterior

2627

Cierre anterior

2628

Genmab A-S Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 oct 2026, 23:56 UTC

Correlated Moves

Texas Instruments Inc is trading higher in after-market hours, advancing after Tuesday's close, while STMicroelectronics NV also gains following three consecutive sessions of increases.

20 oct 2026, 23:56 UTC

Brown & Brown Inc shares are modestly lower in after-market trading, retracing from a peak shortly after the market closed.

20 oct 2026, 23:56 UTC

Bath & Body Works Inc shares declined notably in after-market trading.

20 oct 2026, 23:56 UTC

MetLife Inc shares are trading modestly higher in after-market hours, positioned significantly above its 20-day moving average and near the upper end of its one-month range.

20 oct 2026, 23:56 UTC

Steel Dynamics Inc's shares traded roughly flat in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

20 oct 2026, 23:53 UTC

Mexico's Upcoming Balance of Trade Data on October 27 Sparks Caution Amidst Mixed Sentiment and Political Optimism.

20 oct 2026, 23:52 UTC

News

Northern Trust appoints Rima Qureshi, former Verizon chief strategy officer, to its board of directors, effective immediately, enhancing its technology expertise.

20 oct 2026, 23:51 UTC

RenaissanceRe Holdings Ltd is advancing in after-market trading, reaching its highest cumulative return since Tuesday's close and significantly above its 20-day moving average.

20 oct 2026, 23:51 UTC

FedEx Corp shares are declining in after-market trading.

20 oct 2026, 23:51 UTC

Donnelley Financial Solutions Inc advanced in after-market trading, remaining significantly above its 20-day moving average since Tuesday's close.

20 oct 2026, 23:51 UTC

Axsome Therapeutics Inc shares advanced sharply in after-market trading, rising from a low shortly after the market closed to a session high.

20 oct 2026, 23:51 UTC

Automatic Data Processing Inc is declining in after-market trading, retracing from initial losses and remaining above its 20-day moving average despite the drop.

20 oct 2026, 23:51 UTC

Correlated Moves

Kratos Defense and Security Solutions Inc shares traded higher during after-market hours following the announcement of Rocket Lab Corp's upcoming financial results for Q3 2026.

20 oct 2026, 23:51 UTC

Mattel Inc is advancing in after-market trading, reaching its highest point of the day and remaining above its 20-day moving average.

20 oct 2026, 23:51 UTC

DraftKings Inc shares are trading lower in after-market hours, retracing from an earlier high and nearing their lowest level of the day.

20 oct 2026, 23:51 UTC

Tilray Brands Inc. is advancing in after-market hours, moving higher alongside the broader market, despite recent challenges in the housing sector.

20 oct 2026, 23:51 UTC

Correlated Moves

Wolfspeed Inc. is trading higher in after-market hours, moving alongside the semiconductor sector and the YieldMax Semiconductor Portfolio Option Income ETF (CHPY).

20 oct 2026, 23:51 UTC

Tootsie Roll Industries Inc. is trading modestly higher in after-market hours, reaching its highest cumulative return of the day.

20 oct 2026, 23:51 UTC

Dutch Bros Inc shares traded modestly higher during after-market hours on Tuesday, diverging from the recent trend of higher daily closes.

20 oct 2026, 23:51 UTC

Tractor Supply Co shares fell in after-market trading, declining from earlier gains and experiencing significant volatility since Tuesday's close.

20 oct 2026, 23:51 UTC

Liquidia Corp's shares are trading lower in after-market hours, following a brief rally, amid significant declines in the Pharmaceuticals sub-sector.

20 oct 2026, 23:51 UTC

Shell PLC shares are declining in after-market trading, falling sharply after a period of relative strength above its 20-day moving average.

20 oct 2026, 23:51 UTC

Monster Beverage Corp shares are trading modestly lower in after-market hours, having declined from an early high and falling below Tuesday's close.

20 oct 2026, 23:51 UTC

HCI Group Inc has advanced in after-market trading, showing a notable upward movement since Tuesday's close and peaking above its 20-day moving average.

20 oct 2026, 23:51 UTC

Correlated Moves

Marvell Technology Inc shares are advancing in after-market hours, supported by strength in the semiconductor sector and gains in the iShares Semiconductor ETF.

20 oct 2026, 23:51 UTC

Macro News

The NZD/USD pair is trading higher, supported by a weaker U.S. dollar amid easing inflation concerns and falling crude oil prices.

20 oct 2026, 23:51 UTC

In after-market trading, New York Times Co shares are lower following earlier gains.

20 oct 2026, 23:46 UTC

Papa John's International Inc shares are trading modestly higher in after-market hours, recovering from a low and showing strength after three sessions of declines.

20 oct 2026, 23:46 UTC

Ares Management Corp is trading modestly higher in after-market hours, continuing an upward trend following three consecutive daily gains.

20 oct 2026, 23:46 UTC

Correlated Moves

OneMain Holdings Inc shares advanced modestly higher in after-market trading, coinciding with Capital One Financial's strong third-quarter results that exceeded earnings estimates.

Comparación entre iguales

Cambio de precio

Genmab A-S previsión

Precio Objetivo

By TipRanks

-1.49% descenso

Estimación a 12 Meses

Media 2,493.35 DKK  -1.49%

Máximo 3,320 DKK

Mínimo 308.417 DKK

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Genmab A-S Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

7 ratings

3

Comprar

2

Mantener

2

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Genmab A-S

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.
help-icon Live chat